Institutional investors purchased a net $43.4 thousand shares of PCYC during the quarter ended December 2012. This may signal that the smart money is gaining interest in this company as the 69.02% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 1.9 Million shares of Pharmacyclics Inc
TWO SIGMA INVESTMENTS LLC Bought 551.6 Thousand shares of Pharmacyclics Inc